Integral Diagnostics Limited (ASX:IDX)

Market Cap	913.15M
Revenue (ttm)	627.22M
Net Income (ttm)	4.67M
Shares Out	372.71M
EPS (ttm)	0.02
PE Ratio	162.65
Forward PE	19.48
Dividend	0.07 (2.65%)
Ex-Dividend Date	Aug 29, 2025

Volume	259,506
Average Volume	671,539
Open	2.480
Previous Close	2.480
Day's Range	2.420 - 2.480
52-Week Range	1.910 - 3.150
Beta	0.17
RSI	43.85
Earnings Date	Feb 17, 2026

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as x-ray and EOS. Integral Diagnostics Limited was founded in 1967 and is headquartered in Melbourne, Australia.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1967
• Employees: 3,025
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDX